| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |